201 related articles for article (PubMed ID: 28506088)
1. Trends in white blood cell and platelet indices in a comparison of patients with papillary thyroid carcinoma and multinodular goiter do not permit differentiation between the conditions.
Machairas N; Kostakis ID; Prodromidou A; Stamopoulos P; Feretis T; Garoufalia Z; Damaskos C; Tsourouflis G; Kouraklis G
Endocr Res; 2017 Nov; 42(4):311-317. PubMed ID: 28506088
[TBL] [Abstract][Full Text] [Related]
2. Lack of Variation in Inflammatory Hematological Parameters between Benign Nodular Goiter and Papillary Thyroid Cancer.
Yaylaci S; Tosun O; Sahin O; Genc AB; Aydin E; Demiral G; Karahalil F; Olt S; Ergenc H; Varim C
Asian Pac J Cancer Prev; 2016; 17(4):2321-3. PubMed ID: 27221938
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of platelet indices as a useful marker in papillary thyroid carcinoma.
Dincel O; Bayraktar C
Bratisl Lek Listy; 2017; 118(3):153-155. PubMed ID: 28319410
[TBL] [Abstract][Full Text] [Related]
4. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
5. A comparison of haemogram parameters of patients with thyroid papillary cancer and nodular goiter in Van, Turkey.
Yildiz S; Eker E; Ozturk M; Alay M
J Pak Med Assoc; 2019 Nov; 69(11):1642-1646. PubMed ID: 31740871
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers?
Razavi SA; Modarressi MH; Yaghmaei P; Tavangar SM; Hedayati M
Endocrine; 2017 Sep; 57(3):428-435. PubMed ID: 28755140
[TBL] [Abstract][Full Text] [Related]
7. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M
Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic predictive value of neutrophil-to-lymphocyte ratio in thyroid cancer adjusted for tumor size.
Cheong TY; Hong SD; Jung KW; So YK
PLoS One; 2021; 16(5):e0251446. PubMed ID: 33974674
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid masses: an analysis of 131 cases].
Cağli S; Yüce I; Bayram A; Güney E
Kulak Burun Bogaz Ihtis Derg; 2008; 18(5):289-93. PubMed ID: 19155674
[TBL] [Abstract][Full Text] [Related]
10. Significance of IMP3, nucleophosmin, and Ki-67 expression in papillary thyroid carcinoma.
Yorukoglu A; Yalcin N; Avci A; Cakalagaoglu F; Yaylali G; Akin F; Haciyanli M; Ozden A
Int J Surg Pathol; 2015 Feb; 23(1):5-12. PubMed ID: 25389240
[TBL] [Abstract][Full Text] [Related]
11. Correlation of thyroid fine-needle aspiration with final histopathology: a case series.
Gürkan Dumlu E; Kiyak G; Bozkurt B; Tokaç M; Polat B; Cakir B; Güler G; Kiliç M
Minerva Chir; 2013 Apr; 68(2):191-7. PubMed ID: 23612233
[TBL] [Abstract][Full Text] [Related]
12. Thyroid Follicular Microcarcinoma.
Handra-Luca A
Int J Surg Pathol; 2018 May; 26(3):236-237. PubMed ID: 28954568
[No Abstract] [Full Text] [Related]
13. Characteristics of well-differentiated thyroid cancer associated with multinodular goiter.
Cheng SP; Liu CL; Tzen CY; Yang TL; Jeng KS; Liu TP; Lee JJ
Langenbecks Arch Surg; 2008 Sep; 393(5):729-32. PubMed ID: 18404277
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of CK19, HBME-1 and galectin-3 expressions in differential diagnosis of thyroid papillary microcarcinoma from benign lesions].
Tong J; Wang Y; Da JP
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):599-604. PubMed ID: 22325220
[TBL] [Abstract][Full Text] [Related]
15. DNA repair proteins may differentiate papillary thyroid cancer from chronic lymphocytic thyroiditis and nodular colloidal goiter.
Evren B; Yılmaz S; Karadağ N; Sertkaya AÇ; Topaloğlu Ö; Kılınç F
Sci Rep; 2021 May; 11(1):9932. PubMed ID: 33976347
[TBL] [Abstract][Full Text] [Related]
16. Incidental carcinoma in multinodular goiter: risk factors.
Botrugno I; Lovisetto F; Cobianchi L; Zonta S; Klersy C; Vailati A; Dionigi P; Jemos V
Am Surg; 2011 Nov; 77(11):1553-8. PubMed ID: 22196673
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
18. Mean platelet volume could be a possible biomarker for papillary thyroid carcinomas.
Baldane S; Ipekci SH; Sozen M; Kebapcilar L
Asian Pac J Cancer Prev; 2015; 16(7):2671-4. PubMed ID: 25854344
[TBL] [Abstract][Full Text] [Related]
19. Preoperative platelet distribution width-to-platelet ratio combined with serum thyroglobulin may be objective and popularizable indicators in predicting papillary thyroid carcinoma.
Jin J; Wu G; Ruan C; Ling H; Zheng X; Ying C; Zhang Y
J Clin Lab Anal; 2022 Jun; 36(6):e24443. PubMed ID: 35441746
[TBL] [Abstract][Full Text] [Related]
20. [Morphometric analysis of the degree of thyrocyte aggregation in the preoperative diagnosis of thyroid cancer].
Kirillov VA; Iushchenko IuP
Klin Lab Diagn; 1996; (4):13-6. PubMed ID: 8963549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
